pubrio
Celltrion Inc.

Celltrion Inc.

South Korea · Pharmaceuticals

Pharmaceuticals

Biotechnology

Healthcare

Celltrion Healthcare conducts worldwide marketing, sales, and distribution of biological medicines through an extensive global network that spans more than 110 different countries. Celltrion Healthcare provides REMSIMA, the world's first biosimilar monoclonal antibody (mAb) approved by the European Medicines Agency (EMA) for the treatment of autoimmune disease, and innovative biopharmaceutical medications to help increase patient access to advanced therapies around the world. For additional information on our guidelines, please visit: https://bit.ly/3QyOyt7

Company Insights
Company Overview

1999

Founded

Pharmaceuticals

Industry

South Korea

Location

14,204,701

Ranking

2,400 employees

Size

Similar Companies
Similiar Companies

Get full access to view complete information

Frequently Asked Questions Regarding Celltrion Inc.

Start your journey today

Start with the platform — or start with a conversation

Use Pubrio on your own, or let our team help you with research, lead generation, or data integration.

Talk to Our Team
Start Journey Image
pubrio

Pubrio glocalizes business, people, and intent data from 50+ local sources into one global graph, giving AI and revenue teams full‑market visibility.​

Call Center

85259256922

Our Location

15th Floor ADGM Square, UAE

Social Network

© Pubrio 2026